Company Monitoring Page for Boehringer-Ingelheim

latest headlines for company on cafepharma

Boehringer clears blues to go green, unveiling new corporate branding to convey 'unwavering optimism'
Fierce Pharma
Thu, 11/9/23 - 09:51 am
Tags:
Boehringer Ingelheim, branding
AbbVie, AstraZeneca, Boehringer and more face FTC's ire for 'improper' patent listings
Fierce Pharma
Tue, 11/7/23 - 11:08 pm
Tags:
FTC, Orange Book, patents, AbbVie, AstraZeneca, Boehringer Ingelheim
EU Commission fines pharma companies for price fixing
Reuters
Mon, 10/23/23 - 09:36 am
Tags:
Europe, API, price fixing, antitrust, Alkaloids, Linnea, Boehringer Ingelheim, Transo-Pharm
Chasing Boehringer, Anaptys hits goal in pivotal rare skin disease trial, plans out-licensing deal
Fierce Biotech
Mon, 10/9/23 - 10:11 am
Tags:
AnaptysBio, generalized pustular psoriasis, clinical trials, imsidolimab, Boehringer Ingelheim
Boehringer moves obesity therapy into phase 3
Pharmaphorum
Fri, 10/6/23 - 10:01 am
Tags:
Boehringer Ingelheim, Zealand Pharma, clinical trials, obesity, survodutide
Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar
Fierce Pharma
Wed, 10/4/23 - 11:21 am
Tags:
Boehringer Ingelheim, Cyltezo, biosimilars, Humira, drug pricing
Boehringer launches 81% discounted biosimilar of AbbVie's Humira
Reuters
Mon, 10/2/23 - 06:34 pm
Tags:
Boehringer Ingelheim, biosimilars, AbbVie, Humira, unbranded biosimilars
FDA greenlights Jardiance for treating chronic kidney disease
Medical Marketing and Media
Fri, 09/22/23 - 11:50 am
Tags:
Eli Lilly, Boehringer Ingelheim, Medicare, Jardiance, FDA, chronic kidney disease
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Tue, 08/29/23 - 11:43 am
Tags:
Medicare, HHS, Pfizer, Bristol Myers Squibb, Eli Lilly, Boehringer Ingelheim, AstraZeneca, AbbVie, Novo Nordisk, JNJ, drug pricing
Boehringer Ingelheim Joins Legal Battle Against IRA Drug Pricing Provisions
BioSpace
Tue, 08/22/23 - 09:49 am
Tags:
Boehringer Ingelheim, drug pricing, legal, Medicare, Inflation Reduction Act
Boehringer preps phase 3 for dual-action obesity drug
Pharmaphorum
Thu, 08/17/23 - 09:54 am
Tags:
Boehringer Ingelheim, clinical trials, obesity, survodutide
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
Wed, 08/16/23 - 10:16 am
Tags:
CMS, Medicare, drug pricing, Bristol Myers Squibb, Janssen, Merck, Pfizer, Amgen, Boehringer Ingelheim, Pharmacyclics, AstraZeneca, Astellas, GSK
Spotlight – Nash in 2023 and beyond
EP Vantage
Thu, 08/3/23 - 10:03 am
Tags:
NASH, Boehringer Ingelheim, Zealand Pharma, Akero Therapeutics, Axcella Health, Eli Lilly, Pfizer, Ionis Pharmaceuticals, Cascade, AstraZeneca, Gilead Sciences, Novo Nordisk, Ascletis Pharma, MediciNova
Boehringer Ingelheim posts more Jardiance growth as potential US kidney disease approval nears
Fierce Pharma
Tue, 08/1/23 - 10:35 pm
Tags:
Boehringer Ingelheim, Jardiance, diabetes, earnings
Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
Thu, 07/27/23 - 10:25 am
Tags:
biosimilars, Humira, AbbVie, rebates, drug pricing, Amgen, Celltrion, Novartis, Boehringer Ingelheim, Biocon, Fresenius, Sandoz, Organon, Coherus
AbbVie's Skyrizi delivers head-to-head win versus Amgen's Otezla in psoriasis
Fierce Pharma
Wed, 07/26/23 - 11:37 am
Tags:
AbbVie, Skyrizi, Amgen, Otezla, Boehringer Ingelheim, psoriasis
Jardiance cleared in EU for CKD, challenging Forxiga
Pharmaphorum
Wed, 07/26/23 - 09:45 am
Tags:
Boehringer Ingelheim, Eli Lilly, Jardiance, Europe, chronic kidney disease, Forxiga
Novo Nordisk, Eli Lilly and Boehringer Ingelheim back bill to bring obesity drug coverage to Medicare
Fierce Pharma
Thu, 07/20/23 - 09:42 pm
Tags:
Novo Nordisk, Eli Lilly, Boehringer Ingelheim, obesity
7 companies are rolling out Humira biosimilars
Drugstore News
Wed, 07/12/23 - 09:44 am
Tags:
AbbVie, Humira, biosimilars, Boehringer Ingelheim, Organon, Samsung Bioepsis, Sandoz, Fresenius Kabi, Celltrion, Coherus Biosciences, Biocon
Boehringer's new data drop shows 19% weight loss for phase 2 obesity prospect
Fierce Biotech
Sun, 06/25/23 - 09:46 pm
Tags:
Boehringer Ingelheim, obesity, clinical trials, Zealand Pharma, survodutide

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.